Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast

Journal of Pathology

Volumn 189, Issue 4, 1999, Pages 600-608

  Crescimanno, Caterina ^f   Marzioni, Daniela ^f   Paradinas, Fernando J ^a   Schrurs, Brigitte ^b   Mühlhauser, Judith ^c   Todros, Tullia ^f   Newlands, Edward ^a   David, Guido ^b   Castellucci, Mario ^d,e  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^f Université di Ancona ^*

Author keywords

Choriocarcinoma; Glypican; Hydatidiform mole; Immunohistochemistry; Invasive mole; Placenta; Proteoglycans; Syndecans; Western blot

Indexed keywords

GLYPICAN; SYNDECAN;

ARTICLE; CHORIOCARCINOMA; CONTROLLED STUDY; CYTOTROPHOBLAST; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYNCYTIOTROPHOBLAST; TISSUE DISTRIBUTION; TROPHOBLASTIC DISEASE;

BLOTTING, WESTERN; CHORIOCARCINOMA; FEMALE; HEPARIN; HUMANS; HYDATIDIFORM MOLE; HYDATIDIFORM MOLE, INVASIVE; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, THIRD; PROTEOGLYCANS; SYNDECAN-4; SYNDECANS; TROPHOBLASTS; UTERINE NEOPLASMS;

EID: 0032694234     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199912)189:4<600::AID-PATH440>3.0.CO;2-Q     Document Type: Article

References (37)

1. Ruoslahti E. Proteoglycans in cell regulation. J Biol Chem 1989; 264: 13 369-13 372.
2. Couchman JR, Woods A. Syndecans, signalling, and cell adhesion. J Cell Biochem 1996; 61: 578-584.
3. Woods A, Couchman JR. Syndecans: synergistic activators of cell adhesion. Trends Cell Biol 1998; 8: 189-192.
4. Elenius K, Vainio S, Laato M, Salmivitra M, Thesleff I, Jalkanen M. Induced expression of syndecan in healing wounds. J Cell Biol 1991; 114: 585-595.
5. Bernfield M, Hinkes MT, Gallo RL. Developmental expression of the syndecans: possible function and regulation. Development (Suppl) 1993; 205-212.
6. Leppä S. Härkönen P, Jalkanen M. Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells. Cell Regulation 1991; 2: 1-11.
7. Inki P, Kujari H, Jalkanen M. Syndecan in carcinomas produced from transformed epithelial cells in nude mice. Lab Invest 1992; 66: 314-323.
8. Leppä S, Mali M, Miettinen HM, Jalkanen M. Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc Natl Acad Sci U S A 1992; 89: 932-936.
9. Salmivirta M, Heino J, Jalkanen M. Basic fibroblast growth factor-syndecan complex at cell surface or immobilized to matrix promotes cell growth. J Biol Chem 1992; 267: 17 606-17 610.
10. Inki P, Stenbäck F, Grenman S, Jalkanen M. Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix. J Pathol 1994; 172: 349-355.
11. Salursh M, Reiter RS, Jensen KL, Kato M, Bernfield M. Transient expression of a cell surface heparan sulfate proteoglycan (syndecan) during limb development. Dev Biol 1990; 140: 83-92.
12. Bernfield M, Sanderson R. Syndecan, a morphogenetically regulated cell surface proteoglycan that binds extracellular matrix and growth factors. Philos Trans R Soc London 1990; 327: 171-186.
13. David G, Bai XM, Van der Schueren B, Marynen P, Cassiman JJ, Van den Berghe H. Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development. Development 1993; 119: 841-854.
14. Chernousov MA, Carey DJ. N-syndecan (syndecan-3) from neonatal rat brain binds basic fibroblast growth factor. J Biol Chem 1993; 268: 16 810-16 814.
15. David G, van der Schueren B, Marynen P, Cassiman J-J, van den Berghe H. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J Cell Biol 1992; 118: 961-969.
16. David G, Lories V, Decock B, Marynen P, Cassiman J-J, van den Berghe H. Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J Cell Biol 1990; 111: 3165-3176.
17. Ohlsson R. Growth factors, protooncogenes and human placental development. Cell Differ Dev 1989; 28: 1-16
18. Mühlhauser J, Crescimanno C, Kaufmann P, Höfler H, Zaccheo D, Castellucci M. Differentiation and proliferation patterns in human trophoblast revealed by c-erbB-2 oncogene product and EGF-R. J Histochem Cytochem 1993; 41: 165-173.
19. Castellucci M, Classen-Linke I, Mühlhauser J, Kaufmann P, Zardi L, Chiquet-Ehrismann R. The human placenta: a model for tenascin expression. Histochemistry 1991; 95: 449-458.
20. Mühlhauser J, Crescimanno C, Kasper M, Zaccheo D, Catellucci M. Differentiation of human trophoblast populations involves alterations in cytokeratin patterns. J Histochem Cytochem 1995; 43: 579-589.
21. Benirschke K, Kaufmann P. Pathology of the Human Placenta. 3rd edn. New York: Springer-Verlag, 1995.
22. Damsky CH, Fitzgerald ML, Fisher SJ. Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway in vivo. J Clin Invest 1992; 89: 210-222.
23. Kaufmann P, Castellucci M. Extravillous trophoblast in the human placenta. Trophoblast Res 1997; 10: 21-65.
24. Huppertz B, Kertschanska S, Demir AY, Frank H-G, Kaufmann P. Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta. Cell Tissue Res 1998; 291: 133-148.
25. Mazur MT, Kurman RJ. Gestational trophoblastic disease and related lesions. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. New York: Springer-Verlag, 1994: 1049-1093.
26. Weksberg R, Squire JA, Templeton DM. Glypicans: a growing trend. Nature Genet 1996; 12: 225-227.
27. Bonneh-Barkay D, Shlissel M, Berman B, et al. Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors. J Biol Chem 1997; 272: 12 415-12 421.
28. Nackaerts K, Verbeken E, Deneffe G, Vanderschueren B, Demedts M, David G. Heparan sulfate proteolgycan expression in human lung-cancer cells. Int J Cancer 1997; 74: 335-345.
29. Larrain J, Cizmeci-Smith G, Troncoso V, Stahl RC, Carey DJ, Brandan E. Syndecan-1 expression is down-regulated during myoblast terminal differentiation. J Biol Chem 1997; 272: 18 418-18 424.
30. Mühlhauser J, Marzioni D, Morroni M, Vuckovic M, Crescimanno C, Castellucci M. Codistribution of basic fibroblast growth factor and heparan sulfate proteoglycan in the growth zones of human placenta. Cell Tissue Res 1996; 285: 101-107.
31. Stanley MJ, Liebersbach BF, Liu W, Anhalt DJ, Sanderson RD. Heparan sulfate-mediated cell aggregation. J Biol Chem 1995; 270: 5077-5083.
32. Subramanian SV, Fitzgerald ML, Bernfield M. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem 1997; 272: 14 713-14 720.
33. Oh ES, Woods A, Couchman JR. Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. J Biol Chem 1997; 272: 8133-8136.
34. Polette M, Nawrocki B, Pintiaux A, et al. Expression of gelatinase A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium. Lab Invest 1994; 71: 838-846.
35. Pierleoni C, Badsberg Samuelsen G, et al. Immunohistochemical identification of the receptor for urokinase plasminogen activator associated with fibrin deposition in normal and ectopic human placenta. Placenta 1998; 19: 501-508.
36. Pilia G, Hughes-Benzie RM, MacKenzie A, et al. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nature Genet 1996; 12: 241-247.
37. Lories V, Cassiman JJ, Van den Berghe H, David G. Multiple distinct membrane heparan sulfate proteoglycans in human lung fibroblast. J Biol Chem 1998; 264: 7009-7016.